tcmc at BioJapan 2026: Elevating Cell & Gene Therapy CDMO Services
Taiwan Cell Manufacturing Co., Ltd. (tcmc) will showcase its advanced cell and gene therapy capabilities at BioJapan 2026 in Yokohama, […]
News
tcmc Highlights CAR-T Innovation at BioJapan 2025, Catalyzing Taiwan-Japan Cancer Cell Therapy Partnerships
TOKYO, Oct. 1, 2025 /PRNewswire/ — Taiwan Cell Manufacturing Company (tcmc), a state-of-the-art CDMO specializing in cell and gene therapy (CGT) manufacturing, is participating in BioJapan 2025 – Asia’s premier biotechnology exhibition – taking place October 8-10 in Yokohama, Japan. At this influential event, tcmc will showcase its world-class CDMO services, foster strategic collaborations, and champion innovation in CAR-T cell therapy and regenerative medicine across Asia and beyond…
tcmc、BioJapan 2025でCAR-T療法における革新技術を紹介し、日台間のがん細胞療法分野における連携促進を推進
東京、2025年10月1日 /PRNewswire/ — 細胞・遺伝子治療（CGT）製造に特化した最先端CDMO企業である台灣細胞製造股份有限公司（tcmc）は、10月8日から10日にかけて横浜で開催される、[バイオビジネスにおけるアジア最大のパートナリングイベント- BioJapan 2025]に出展します…
tcmc to Showcase Asia’s Leading Cell & Gene Therapy CDMO Capabilities at BIO 2025 International Convention
Taiwan Cell Manufacturing Company (tcmc), a leading Contract Development and Manufacturing Organization (CDMO) in cell and gene therapy (CGT), will